dr claire diver phd pgcertres mcsp fsom
TRANSCRIPT
![Page 1: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/1.jpg)
Dr Claire Diver
PhD PGCertRes MCSP FSOM
![Page 2: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/2.jpg)
} Answer following questions: ◦ Why aspirate? ◦ What is the clinical significance of aspirate? ◦ What is the most accurate approach for needle
placement in the knee joint? ◦ Are there prognostic indicators of outcome in OA
knee management with corticosteroid injection?
![Page 3: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/3.jpg)
Diagnosis 1. Acute synovitis ◦ Sepsis ◦ Crystals
� Common: monosodium urate (MSU); calcium pyrophosphate (CPPD)
� Rare: oxalate; cholesterol 2. Chronic arthropathy ◦ Crystals (MSU; CPPD) Courtney and Doherty, 2005 Courtney and Doherty, 2009
![Page 4: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/4.jpg)
Treatment 1. Common ◦ To decrease intra-articular pressure ◦ Injection of steroid
2. Less common ◦ Recurrent aspiration for sepsis ◦ Saline lavage for resistant arthropathy
Courtney and Doherty, 2005 Courtney and Doherty, 2009
![Page 5: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/5.jpg)
} Research ◦ Measuring biomarkers of joint disease especially OA ◦ Need to compare SF from normal joints with
diseased joints
Pascual and Doherty, 2009
![Page 6: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/6.jpg)
} Aseptic no-touch technique } Gloves- to protect operator } Position patient with joint relaxed } Avoid blood vessels or cellulitis at the point of
entry } 21g or larger needle for knee } 20ml syringe } Synovial fluid collection bottles: ? Glass phial/
tube to view fluid } If using CSI then do not aspirate to dryness
Courtney and Doherty, 2005 Courtney and Doherty, 2009
![Page 7: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/7.jpg)
![Page 8: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/8.jpg)
![Page 9: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/9.jpg)
} Incorrect needle placement } If flow of aspiration ceases: ◦ Obstruction by synovial fronds ◦ Obstruction by fibrin and debris ◦ Loculation of synovial fluid ◦ Needle displacement during technique
Courtney and Doherty, 2005
![Page 10: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/10.jpg)
Courtney and Doherty, 2009
![Page 11: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/11.jpg)
Courtney and Doherty, 2009
![Page 12: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/12.jpg)
Courtney and Doherty, 2009
![Page 13: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/13.jpg)
Courtney and Doherty, 2009
![Page 14: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/14.jpg)
Courtney and Doherty, 2009
![Page 15: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/15.jpg)
Supero-lateral Supero-medial
Hermans, J., et al 2011
![Page 16: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/16.jpg)
Medial mid-patellar Lateral mid-patellar
Hermans, J., et al 2011
![Page 17: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/17.jpg)
Antero-medial Antero-lateral
Hermans, J., et al 2011
![Page 18: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/18.jpg)
} Systematic review: Hermans, J., et al 2011. } 9 articles: reviewed using QUADAS risk of bias
tool } Superolateral approach studied most (n=6)
Where effusion or synovitis present (2 studies) pooled accuracy was 98% (95%CI 95-100%)
} Length of needle 1.5-2” increased accuracy } 1 study identified addition of traction in patients
with K&L OA Grade IV increased accuracy in antero-medial and antero-lateral approaches
} N=1 adverse event
![Page 19: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/19.jpg)
} Systematic review: Maricar et al, 2013 } 11 studies: meta-analysis not possible given
large degree of heterogeniity } Possible predictors include: ◦ Effusion ◦ Aspiration ◦ Disease severity ◦ US guided injections
![Page 20: Dr Claire Diver PhD PGCertRes MCSP FSOM](https://reader031.vdocuments.mx/reader031/viewer/2022020623/61f1b80b49a3cd3ead5a209d/html5/thumbnails/20.jpg)